Parvovirus В19 infection: lecture
https://doi.org/10.22627/2072-8107-2022-21-3-39-46
Abstract
Parvovirus B19 infection is best known as erythema infectiosum. However, infection with parvovirus B19 can lead to damage to various organs and systems, the development of severe complications up to death. The infection is most dangerous for people with immunodeficiency and hematological diseases. Serious consequences are possible with intrauterine infection of the fetus. Knowledge about the characteristics of the pathogen, the pathogenesis of the disease, the variety of clinical manifestations will allow the doctor to avoid diagnostic errors and provide the patient with timely medical care.
About the Authors
T. M. Chernova
St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Chernova Т., PhD
V. N. Timchenko
St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
E. B. Pavlova
St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Pavlova Е., PhD
E. V. Baracina
St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Barakina Е., PhD
M. D. Subbotina
St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Subbotina М., PhD
References
1. Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet. 1975; 1:72—73.
2. Serjeant GR, Topley JM, Mason K, Serjeant BE, Pattison J.R., Jones S.E., Mohamed R. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet. 1981; 2(8247): 595—597. doi: 10.1016/s0140-6736(81)92739-2.
3. Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. J Internal Med. 2006; 260(4):285—304. https://doi.org/10.1111/j.1365-2796.2006.01697.x
4. Ivanova SК, Mihneva ZG, Toshev AК, Kovaleva VР, Andonova LG, Muller CP, Hübschen JuM. Insights into epidemiology of human parvovirus B19 and detection of an unusual genotype 2 variant, Bulgaria, 2004 to 2013. Euro Surveill. 2016; 21(4). doi: 10.2807/1560-7917.ES.2016.21.4.30116.
5. Servant-Delmas A, Lefrère JJ, Morinet F, Pillet S. Advances in Human B19 Erythrovirus Biology. J Viroligy, 2010; 84(19):9658—9665. doi:10.1128/JVI.00684-10
6. Rasulova MB, Kasimova RI, Musabaev EI. Epidemiology of parvovirus b19 infection, clinical manifestations and pathogenetic aspects in children. European Journal of Molecular medicine. 2021; 1(4):10—20. https://ejournals.id/index.php/EJMM/article/view/275 [date of access 16.07.22]
7. Timchenko V.N., Khmilevskaya S.A., Zaslavsky D.V. Exanthema in children: a photo-illustrated guide to diagnosis and treatment. St. Petersburg: SpecLit. 2022:83—89. (in Russ.)
8. Lokteva L.M., Pulatova R.Z., Aliyeva L.E., Musabaev E.I. Clinical manifestations of parvoviral infection in Uzbekistan. Epidemiology and Infectious Diseases. 2019; 24(5—6):229—233. (in Russ.). doi: 10.17816/EID34805
9. Cennimo DJ, Dieudonne A. Parvovirus B19 Infection. Medscape. Oct 11, 2019. https://emedicine.medscape.com/article/961063-overview [date of access 16.07.22]
10. Parvovirus B19 infection is congenital. Clinical guidelines, 2016. (in Russ.)
11. Weigel-Kelley KA., Yoder MC., Srivastava А. Alpha5beta1 integrin as a cellular coreceptor for human Parvovirus B19: Requirement of functional activation of beta1 integrin for viral entry. Blood. 2004; 102(12):3927—3933. doi: 10.1182/blood-2003-05-1522
12. Runov A., Kurchakova E., Khashchevskaya D., Moiseeva O., Mitrofanova L., Vonsky M. Expression of viral receptors and the development of myocarditis. Proceedings of the Institute of Poliomyelitis and Viral Encephalitis named after M.P. Chumakova RAMS, Medical Virology. 2016; 30(1):39—47. (in Russ.)
13. Verdonschot J, Hazebroek М, Merken J, Debing Ya, Dennert R, Brunner-La Rocca H-P, Heymans S. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature. Eur J Heart Fail. 2016; 18(12):1430—1441. doi: 10.1002/ejhf.665.
14. Luo Y, Qiu J. Human parvovirus B19: a mechanistic overview of infection and DNA replication. Future Virol. 2015; 10(2):155—167. doi: 10.2217/fvl.14.103
15. Cassinotti P, Burtonboy G, Fopp M, Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol. 1997; 53(3):229—32.
16. Kerr JR. The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease. J Clin Pathol. 2016; 69(4):279—91. doi: 10.1136/jclinpath-2015-203455.
17. Ilienko L.I., Pashinyan A.G., Vasenova V.Yu. Clinical case of skin lesions with parvovirus B19 infection. Detskie Infektsii=Children's Infections. 2018; 17(3):68—71. (In Russ.) https://doi.org/10.22627/2072-8107-2018-17-3-68-71
18. Sharipova E.V., Babachenko I.V. Clinical and epidemiological features of parvovirus B19 infection in children. Pediatriya=Pediatrics. 2015; 94(2):82—86. (In Russ.)
19. Molochkova O.V. , N.Yu. Egorova, N.A. Guseva, O.V. Shamsheva On the issue of differential diagnosis of infectious exanthems in children: a clinical case of infectious erythema of parvovirus etiology. Pediatriya=Pediatrics. 2019; 98(1):159—164. (In Russ.) https://doi.org/10.24110/0031-403X-2019-98-1-159-164
20. Oguz F, Akdeniz C, Unuvar E, Kucukbasmaci O, Sidal M. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis. J Paediatr Child Health. 2002; 38:358—362. https://doi.org/10.1046/j.1440-1754.2002.00789.x
21. Tesapirat L, Wanlapakorn N, Chieochansin Th, Poovorawan Y. Parvovirus b19 infection presenting as acute hepatitis and transient anemia in a previously healthy child. Southeast Asian J Trop Med Public Health. 2015; 46(2):226—30.
22. Sobolevskiy K.V., Otmakhova I.A., Gadirova B.Y., Zueva Z.E. Clinical case of acute hepatitis caused by parvovirus B 19. Journal Infectology. 2021; 13(2):154—158. (In Russ.) https://doi.org/10.22625/2072-6732-2021-13-2-154-158]
23. Mogensen TH, Jensen JMB, Hamilton-Dutoit S, Larsen CS. Chronic hepatitis caused by persistent parvovirus B19 infection. BMC Infect Dis. 2010; 10:246. doi: 10.1186/1471-2334-10-246.
24. Chernova Т.М., Dubko M.F., Parvovirus B19 as a cause of carditis in combination with myositis. Medicinskij Sovet=Medical Advice. 2018, 2:191—193. (In Russ.) https://doi.org/10.21518/2079-701X-2018-2-190-193
25. Esmel-Vilomara R, Dolader Р, Izquierdo-Blasco J, Balcells J, Sorlí М, Escudero F, Vera Е, Gran F. Parvovirus B19 myocarditis in children: a diagnostic and therapeutic approach. Eur J Pediatr. 2022; 181(5):2045—2053. doi: 10.1007/s00431-022-04406-x.
26. Vigneswaran TV, Brown JR, Breuer J, Burch М. Parvovirus B19 myocarditis in children: an observational study. Arch Dis Child. 2016; 101(2):177—80. doi: 10.1136/archdischild-2014-308080
27. Mathew A, Abuhammour W, Fathalla B, Otour.В. Parvovirus B19 Infection Mimicking Juvenile Myelomonocytic Leukemia in an Immunocompetent Child. Cureus. 2020; 12(6):e8854. doi:10.7759/cureus.8854
28. Ugai S, Aizawa Yu, Kanayama Т, Saitoh А. Parvovirus B19: A Cause of Sepsislike Syndrome in an Infant. Pediatrics. 2018; 141(6):e20171435. https://doi.org/10.1542/peds.2017-1435
29. Saad АА, Beshlawi I, Al-Rawas АН, Zachariah М, Nazir HF, Wali Ya. Human Parvovirus B19 in Children with Sickle Cell Disease; Poking the Spleen. Oman Med J. 2017; 32(5):425—428. doi: 10.5001/omj.2017.79
30. de la Hoz JA, Otones LL, Sáenz MH, Martín MJR. Parvovirus b19 infection in children with sickle cell disease, watch out for splenomegaly! A case report. Afri Health Sci. 2022; 22(1):598—601. https://dx.doi.org/10.4314/ahs.v22i1.69
31. Luna JM, Wintermark М, Hills NK, Tokarz R, Li Yi, Glaser С, DeVeber GA., Lipkin WI, Elkind MSV. Parvovirus B19 Infection in Children With Arterial Ischemic Stroke. Stroke. 2017; 48(10):2875—
32. https://doi.org/10.1161/STROKEAHA.117.018272
33. Yu Q, Tan R, Zhao J, Zhou Q, Zheng F, Li Х. Parvovirus B19 associated autoantibodies upregulation in women and children in Southern China. J Lab Med. 2021; 45(3):179—182 https://doi.org/10.1515/labmed-2020-0120
34. Heidari Z, Jami М. Parvovirus B19 Infection Is Associated with Autoimmune Thyroid Disease in Adults. Int J Endocrinol Metab. 2021; 19(4):e115592. doi: 10.5812/ijem.115592
35. Crane J., Mundle W., Boucoiran I., Gagnon R., Bujold E., Basso M., Bos H., Brown R., Cooper S., Gouin K, McLeod N. L., Menticoglou S., Mundle W., Pylypjuk Ch., Roggensack A., Sanderson F. Parvovirus B 19 infection in pregnancy. J Obstet Gynaecol Can. 2014; 36(12):1107—1116. doi: 10.1016/S1701-2163(15)30390-X.
36. Ushakova R.A. Parvovirus infection B19 in pediatric practice: features of clinical manifestations and ways to solve the problem. Actual issues of pediatric cardiology and rheumatology: materials of the Anniversary Scientific and Practical Conference of the City Children's Cardio-Rheumatological Center of the GAUZ SO «DGKB No. 11» (October 29—30, 2021). Yekaterinburg: AMB, 2021: 95—100 (In Russ.) http://elib.usma.ru/bitstream/usma/4780/1/USMU_Sbornik_statei_2021_012.pdf] [date of access 16.07.22]
37. Zykova T.A., Shevyakova E.A. Parvovirus B19: features of distribution in cancer patients. Rossijskij Мedicinskij Zhurnal=Russian Мedical Journal. 2018; 24(4):206—212. (In Russ.) https://doi.org/10.18821/0869-2106-2018-24-4-206-212
38. Roppelt A.A., Vasilyeva A.P., Kalinina I.I., Baidildina D.D., Suntsova E.V., Salimova T.Yu., Petrova U.N., Fisyun I.V., Raikina E.V., Goronkova O.V., Maschan M.A., Maschan A.A. Clinical manifestations and laboratory features of acute parvovirus infection in children with oncohematological diseases (Review of literature and clinical case reports). Pediatric Hematology/Oncology and Immunopathology. 2015; 14(4):25-31. (In Russ.) https://doi.org/10.24287/1726-1708-2015-14-4-25-31
39. Kerr JR Mattey DL. The role of parvovirus B19 and the immune response in the pathogenesis of acute leukemia. Rev Med Virol. 2015; 25(3):133—55. doi: 10.1002/rmv.1830.
40. Liang Y, Ding L, Li X, Wang W, Zhang X. Transient pancytopenia preceding adult acute lymphoblastic leukemia with chromosomal abnormalities including the Philadelphia chromosome: A case report and review of the literature. Oncol Lett. 2015; 10(6):3789—3792. doi: 10.3892/ol.2015.3766
41. Ashaka OS, Agbede OO, Omoare AA, Ernest SK. Human parvovirus B19-induced anaemia in pre-school children in Ilorin, Nigeria. Afr J Lab Med. 2018; 7(1):615. doi: 10.4102/ajlm.v7i1.615
42. Jo KJ, Lee YeJ, Park KM, Yang EJ, Yoo S, Lim TJ, Park SE. Clinical Characteristics of Human Parvovirus B19 Infection in Children. Pediatr Infect Vaccine. 2020; 27(2):111—116. https://doi.org/10.14776/piv.2020.27.e14
43. Anokhin V.A., Sabitova A.M., Aglyamova T.A., Minaeva E.Y., Marchenkova N.A., Knyazeva O.Y. Parvovirus infection in children. Detskie Infektsii=Children's Infections. 2019;18(1):22—28. (In Russ.) https://doi.org/10.22627/2072-8107-2019-18-1-22-28
44. Grineva A.A., Vasilev V.V., Kashtanova T.A., Kyanksep I.V. Antenatal diagnostic and treatment of congenital infection coused by parvovirus B19 (clinical case). Journal Infectology. 2020;12(4):109—113. (In Russ.) https://doi.org/10.22625/2072-6732-2020-12-4-109-113
45. Kadyrberdieva F.Z, Tetruashvili N.K., Shmakov R.G., Bokeria E.L, Kostyukov K.V., Kim L.V., Bystrykh O.A, Donnikov A.E, Podurovskaya Yu.L Successful pregnancy outcome in non-immune fetal hydrops due to parvovirus B19. Akusherstvo i Ginekologiya=Obstetrics and Gynecology. 2020; 3:238—244. (In Russ.) doi: https://dx.doi.org/10.18565/aig.2020.3.238-244
46. Ballou WR, Reed JL, Noble W, Young NS, Koenig S. Safety and Immunogenicity of a Recombinant Parvovirus B19 Vaccine Formulated with MF59C.1. J Infect Dis. 2003; 187(4):675—8. doi: 10.1086/368382.
Review
For citations:
Chernova T.M., Timchenko V.N., Pavlova E.B., Baracina E.V., Subbotina M.D. Parvovirus В19 infection: lecture. CHILDREN INFECTIONS. 2022;21(3):39-46. (In Russ.) https://doi.org/10.22627/2072-8107-2022-21-3-39-46
Views:
690
Email this article 